Allogene Therapeutics

ALLO

NASDAQHealth Care

Income Statement

Total Revenue$22K

Gross Profit$22K

Operating Income$-273.2M

EBITDA$-243.33M

EBIT$-256.97M

Pre-tax Income$-190.89M

Net Income$-257.59M

Cash Equivalent$97.33M

Total Debt$21.28M

Book Value$465.58M

Book Value Per Share2.45

Return on Equity (ROE)-61.01%

Return on Assets (ROA)-46.94%

Return on Invested Capital (ROI)-61.01%

Net Profit Margin-1170863.64%

Current Ratio8.54

Quick Ratio8.29

Long-Term Debt / Equitynull